Moreover, USP39 was found to be overexpressed in high-grade serous ovarian carcinoma (HGSOC) and promotes ovarian cancer malignancy, thereby involved in the poor prognosis of patients with HGSOC [43]. The gene discussed is USP39; the disease is ovarian cancer.